Diagnostic Workup for Pleural Effusion
Begin with chest radiography as initial imaging, followed by thoracentesis with pleural fluid analysis (including Light's criteria, cytology, and microbiological studies) for all patients with clinically significant pleural effusion, and proceed to thoracic ultrasound or CT chest with contrast if the diagnosis remains unclear or to guide interventions. 1, 2
Initial Imaging Approach
Chest radiography is the appropriate first-line imaging modality, capable of detecting >75 mL on lateral view and >175 mL on frontal view 1. However, recognize its limitations:
- Thoracic ultrasound detects as little as >20 mL of fluid and should be used when clinical suspicion is high despite negative or equivocal radiographs 1
- CT chest is the reference standard, detecting >10 mL of fluid, and should be obtained when:
- The etiology remains unclear after initial workup
- You need to characterize pleural disease (nodularity, thickening)
- You're planning image-guided procedures
- Underlying parenchymal disease needs evaluation 1
Pleural Fluid Analysis: The Critical Step
Perform thoracentesis on all new, unexplained pleural effusions unless the clinical picture clearly indicates transudative effusion from heart failure, cirrhosis, or renal failure that responds to treatment 2.
Volume Requirements and Specimen Handling
- Send 25-50 mL for cytology in suspected malignancy (smaller volumes acceptable but reduce sensitivity) 2
- Send fluid in both plain containers AND 5-10 mL inoculated into aerobic/anaerobic blood culture bottles when infection is possible 2
- If limited volume available, prioritize blood culture bottles (2-5 mL) over plain containers 2
Essential Pleural Fluid Tests
Order these tests systematically:
- Appearance (bloody, purulent, chylous)
- Light's criteria to distinguish transudate vs. exudate:
- Pleural fluid protein/serum protein >0.5
- Pleural fluid LDH/serum LDH >0.6
- Pleural fluid LDH >2/3 upper limit of normal serum LDH
- Cell count with differential
- Cytology (direct smear and cell block preparation) 2
- Microbiological studies (Gram stain, culture in blood culture bottles) 2
- pH and glucose if infection suspected
Specialized Biomarker Testing
Consider these based on clinical context:
- Adenosine deaminase (ADA) and/or interferon-gamma for tuberculous effusion in high-prevalence populations (use ADA as exclusion test in low-prevalence areas) 2
- Pleural fluid ANA to support lupus pleuritis diagnosis 2
- Serum NT-proBNP (not pleural fluid) for suspected heart failure with unilateral effusion 2
Do NOT routinely order: Pleural fluid biomarkers for secondary malignancy, pleural fluid NT-proBNP (serum is superior), or serum biomarkers for pleural infection 2
When Initial Workup is Non-Diagnostic
If thoracentesis and imaging don't establish diagnosis, proceed to tissue sampling:
- Thoracoscopic or image-guided pleural biopsy depending on clinical indication and local expertise 2
- Never perform blind (non-image-guided) pleural biopsies 2
- Consider direct biopsy earlier for tumor types with low cytological yield (especially mesothelioma) 2
Critical Pitfalls to Avoid
- Don't rely on physical examination alone - it has poor sensitivity for detecting effusions 1
- Don't assume negative cytology excludes malignancy - sensitivity varies by tumor type; repeat sampling or proceed to biopsy 2
- Don't miss evolving empyema - in pneumonia-associated effusions, monitor closely and sample early if infection suspected 2
- Don't send inadequate fluid volumes - this is the most common reason for non-diagnostic results 2
- Don't order pleural fluid biomarkers for malignancy diagnosis - they lack sufficient diagnostic accuracy 2
Algorithmic Summary
- Chest X-ray → If effusion present and unexplained
- Thoracentesis with comprehensive fluid analysis (appearance, Light's criteria, cytology, cultures, specialized tests based on differential)
- If diagnosis unclear → CT chest with contrast
- If still unclear → Image-guided or thoracoscopic pleural biopsy
- Throughout: Use ultrasound guidance for all pleural procedures to reduce complications 2